FDA Orange Book · active-ingredient family
Norfloxacin
Norfloxacin is approved in 2 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:NOROXIN · NDA 019384
2
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · solution/drops, tablet
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| NOROXINRLD | MERCK | NDA 019384 | — | Oct 31, 1986 | |
| CHIBROXIN | MERCK | NDA 019757 | — | Jun 17, 1991 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Norfloxacin — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

